Almac launches pod for GDP, temperature-controlled shipping

By Melissa Fassbender

- Last updated on GMT

The Almac Pod™ is fully GDP-compliant. (Image: Almac Group)
The Almac Pod™ is fully GDP-compliant. (Image: Almac Group)

Related tags Supply chain Supply chain management

The contract development and manufacturing organization (CDMO) launched its new Almac Pod™ service solution to safeguard customer’s products.

The temperature-controlled shipping service solution provides an option as companies need to meet increasingly strict Good Distribution Practices. Additionally, the increasing number of biologics requires more temperature-controlled shipping solutions.

As we previously reported​, nearly three-fourths of biologic drugs are temperature controlled – and nearly one third of all drugs in development are associated with biologic material.

According to Almac, The Almac Pod™ incorporates the company’s  global courier network and advanced phase change technology (PCM) to provide a temperature-controlled shipping service solution. The company also said that since service-launch the Pod has been 100% effective in protecting the integrity of shipped products.

With rapid growth in the volume of our controlled temperature shipments over the past few years, the introduction of innovative solutions such as the Almac Pod™ allows us to deliver on the growing needs of our clinical trial supply customers​,” said Andrew Scott, Head of Logistics (EU) at Almac.

The Almac Pod™ is fully GDP-compliant and is available as part of Almac’s end-to-end, global supply chain management solution.

Related news

Show more

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers